Can less Anti-Rejection meds save transplanted kidneys?

This study looked at whether giving kidney transplant patients a lower dose of the anti-rejection drug cyclosporine, along with another drug called mycophenolate mofetil, could help protect their kidney function over two years. The study involved 208 adults who had received a kidney transplant from a deceased donor and were at least one year post-transplant. Researchers measured kidney function, side effects, and rates of rejection to see if the lower-dose approach was safe and effective.